Live Feeds

Source map — Lilly sets up next-gen obesity battle with full phase 3 retatrutide data

Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.

SourceTypeTrust
NBC News news 60%
Fierce Biotech news 60%
CNBC news 60%
Eli Lilly news 60%
The Guardian news 60%
USA Today news 60%
www.thebionews.net news 50%
abc13.com news 50%
luxaralabs.com news 50%
tirzepatidereview.com news 50%
romickinoakley.wordpress.com news 50%
trials.lilly.com news 50%
retatrutidereport.com news 50%
peptoclinic.com news 50%
retatrutide.med news 50%
kures.co news 50%
welltica.com news 50%
beautybypeptides.com news 50%
www.biospace.com news 50%
abcnews.com news 50%
nypost.com news 50%
www.yahoo.com news 50%
onthepen.com news 50%
www.scientificamerican.com news 50%
www.prnewswire.com news 50%
theclinicaltimes.com news 50%
en.wikipedia.org news 50%
careers.lilly.com news 50%
finance.yahoo.com news 50%
www.medicaldaily.com news 50%
www.technologyreview.com news 50%
www.newsweek.com news 50%
www.glp3.wiki news 50%
www.matterfact.com news 50%
www.onedaymd.com news 50%
glpplaybook.com news 50%
pepsreview.com news 50%
www.retaweightloss.com news 50%
remyresearch.com news 50%